A world where the tech giant gets dismantled is more plausible than it was, but investors have reason to be unfazed
CBO analysis says savings from other health benefits would not offset the expense of weight-loss jabs
Fund run by Jeff Smith builds $1bn stake in vaccine maker and pitches shake-up plan
Bill Ford says his approach would not change if carried interest loophole is closed
Deal would bolster Japanese group’s drive to secure supplies for home country, which relies on fossil fuel imports for energy
GLP Capital deal will add $44bn in assets to private investment group’s business
The drugmaker is worth less now than before the pandemic
Plus, Jane Street comes for Goldman’s trading crown and Byju’s can’t find the money
Loan growth has been sluggish as higher interest rates have deterred borrowers
Injunction is a blow to search giant defending three antitrust cases that threaten its core business
Ian Read has called his successors about the activist’s ideas for turning round the vaccine maker
Upstart chipmaker hopes to take on industry champ Nvidia with its larger-than-life AI wafers
Biggest US antitrust victory since Microsoft could still be too little, too late, as judge considers how to rein in search giant
A quirky and opaque New York firm has rapidly expanded to become the most profitable trader of all
Agreement with US tech company is set to provide a boost to broadcasters’ new platform Freely
Pharma giant’s share price has fallen below pre-pandemic levels after shortlived bump from Covid vaccine
Owner of 7-Eleven brand considers disposing of supermarket chain and selling stake in Seven Bank
Complicated corporate structures cannot force leaders to agree and makes fundraising more difficult
US biotech researches treatments to reduce muscle loss from blockbuster diet medicines
Tens of thousands of picketing machinists dig in as plane maker reels from latest crisis
More companies are reaching the $1bn valuation milestone, but growing from horned foal to winged steed is getting tougher
Andreessen Horowitz co-founder previously backed Trump but will make personal contribution to Democratic candidate after Biden dropped out
The Apollo chief believes we are on the cusp of a new era in finance
Instagram and Facebook owner says new tools trump rivals’ but will not be widely available until next year at the earliest
Plus, Kamala Harris drums up support from Wall Street and Chinese biopharma companies consider asset sales as new US regulations loom
